| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cadherin binding | 1.89e-04 | 339 | 32 | 5 | GO:0045296 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | 2.64e-04 | 1099 | 32 | 8 | GO:0008092 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | 3.31e-04 | 599 | 32 | 6 | GO:0050839 | |
| GeneOntologyMolecularFunction | structural molecule activity | 2.60e-03 | 891 | 32 | 6 | GO:0005198 | |
| GeneOntologyMolecularFunction | cell-cell adhesion mediator activity | 4.29e-03 | 61 | 32 | 2 | GO:0098632 | |
| GeneOntologyBiologicalProcess | positive regulation of metanephric DCT cell differentiation | 2.33e-06 | 2 | 32 | 2 | GO:2000594 | |
| GeneOntologyBiologicalProcess | negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis | 2.33e-06 | 2 | 32 | 2 | GO:0072305 | |
| GeneOntologyBiologicalProcess | regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis | 2.33e-06 | 2 | 32 | 2 | GO:0072304 | |
| GeneOntologyBiologicalProcess | kidney field specification | 2.33e-06 | 2 | 32 | 2 | GO:0072004 | |
| GeneOntologyBiologicalProcess | regulation of apoptotic process involved in metanephric collecting duct development | 2.33e-06 | 2 | 32 | 2 | GO:1900214 | |
| GeneOntologyBiologicalProcess | negative regulation of apoptotic process involved in metanephric collecting duct development | 2.33e-06 | 2 | 32 | 2 | GO:1900215 | |
| GeneOntologyBiologicalProcess | negative regulation of apoptotic process involved in metanephric nephron tubule development | 2.33e-06 | 2 | 32 | 2 | GO:1900218 | |
| GeneOntologyBiologicalProcess | regulation of apoptotic process involved in metanephric nephron tubule development | 2.33e-06 | 2 | 32 | 2 | GO:1900217 | |
| GeneOntologyBiologicalProcess | pronephric field specification | 2.33e-06 | 2 | 32 | 2 | GO:0039003 | |
| GeneOntologyBiologicalProcess | mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis | 2.33e-06 | 2 | 32 | 2 | GO:1901147 | |
| GeneOntologyBiologicalProcess | pattern specification involved in pronephros development | 2.33e-06 | 2 | 32 | 2 | GO:0039017 | |
| GeneOntologyBiologicalProcess | apoptotic process involved in metanephric nephron tubule development | 2.33e-06 | 2 | 32 | 2 | GO:1900205 | |
| GeneOntologyBiologicalProcess | apoptotic process involved in metanephric collecting duct development | 2.33e-06 | 2 | 32 | 2 | GO:1900204 | |
| GeneOntologyBiologicalProcess | regulation of metanephric DCT cell differentiation | 2.33e-06 | 2 | 32 | 2 | GO:2000592 | |
| GeneOntologyBiologicalProcess | mesenchymal stem cell maintenance involved in metanephric nephron morphogenesis | 6.99e-06 | 3 | 32 | 2 | GO:0072309 | |
| GeneOntologyBiologicalProcess | metanephric DCT cell differentiation | 6.99e-06 | 3 | 32 | 2 | GO:0072240 | |
| GeneOntologyBiologicalProcess | kidney rudiment formation | 6.99e-06 | 3 | 32 | 2 | GO:0072003 | |
| GeneOntologyBiologicalProcess | DCT cell differentiation | 6.99e-06 | 3 | 32 | 2 | GO:0072069 | |
| GeneOntologyBiologicalProcess | positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis | 1.40e-05 | 4 | 32 | 2 | GO:0072108 | |
| GeneOntologyBiologicalProcess | negative regulation of mesenchymal cell apoptotic process involved in metanephros development | 1.40e-05 | 4 | 32 | 2 | GO:1900212 | |
| GeneOntologyBiologicalProcess | regulation of mesenchymal cell apoptotic process involved in metanephros development | 1.40e-05 | 4 | 32 | 2 | GO:1900211 | |
| GeneOntologyBiologicalProcess | mesenchymal cell apoptotic process involved in nephron morphogenesis | 1.40e-05 | 4 | 32 | 2 | GO:1901145 | |
| GeneOntologyBiologicalProcess | negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis | 1.40e-05 | 4 | 32 | 2 | GO:0072040 | |
| GeneOntologyBiologicalProcess | regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis | 1.40e-05 | 4 | 32 | 2 | GO:0072039 | |
| GeneOntologyBiologicalProcess | metanephric nephron tubule formation | 1.40e-05 | 4 | 32 | 2 | GO:0072289 | |
| GeneOntologyBiologicalProcess | mesenchymal cell apoptotic process involved in metanephros development | 1.40e-05 | 4 | 32 | 2 | GO:1900200 | |
| GeneOntologyBiologicalProcess | metanephric distal convoluted tubule development | 2.33e-05 | 5 | 32 | 2 | GO:0072221 | |
| GeneOntologyBiologicalProcess | metanephric distal tubule development | 2.33e-05 | 5 | 32 | 2 | GO:0072235 | |
| GeneOntologyBiologicalProcess | distal convoluted tubule development | 2.33e-05 | 5 | 32 | 2 | GO:0072025 | |
| GeneOntologyBiologicalProcess | negative regulation of somatic stem cell population maintenance | 2.33e-05 | 5 | 32 | 2 | GO:1904673 | |
| GeneOntologyBiologicalProcess | metanephric tubule formation | 3.48e-05 | 6 | 32 | 2 | GO:0072174 | |
| GeneOntologyBiologicalProcess | negative regulation of apoptotic process involved in morphogenesis | 4.87e-05 | 7 | 32 | 2 | GO:1902338 | |
| GeneOntologyBiologicalProcess | regulation of metanephric nephron tubule epithelial cell differentiation | 4.87e-05 | 7 | 32 | 2 | GO:0072307 | |
| GeneOntologyBiologicalProcess | positive regulation of epithelial cell differentiation involved in kidney development | 4.87e-05 | 7 | 32 | 2 | GO:2000698 | |
| GeneOntologyBiologicalProcess | metanephric collecting duct development | 4.87e-05 | 7 | 32 | 2 | GO:0072205 | |
| GeneOntologyBiologicalProcess | metanephric nephron tubule epithelial cell differentiation | 4.87e-05 | 7 | 32 | 2 | GO:0072257 | |
| GeneOntologyBiologicalProcess | metanephric nephron tubule morphogenesis | 4.87e-05 | 7 | 32 | 2 | GO:0072282 | |
| GeneOntologyBiologicalProcess | mesenchymal stem cell maintenance involved in nephron morphogenesis | 4.87e-05 | 7 | 32 | 2 | GO:0072038 | |
| GeneOntologyBiologicalProcess | negative regulation of apoptotic process involved in development | 6.49e-05 | 8 | 32 | 2 | GO:1904746 | |
| GeneOntologyBiologicalProcess | pattern specification involved in kidney development | 6.49e-05 | 8 | 32 | 2 | GO:0061004 | |
| GeneOntologyBiologicalProcess | renal system pattern specification | 6.49e-05 | 8 | 32 | 2 | GO:0072048 | |
| GeneOntologyBiologicalProcess | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis | 8.34e-05 | 9 | 32 | 2 | GO:0003339 | |
| GeneOntologyBiologicalProcess | metanephric tubule morphogenesis | 1.04e-04 | 10 | 32 | 2 | GO:0072173 | |
| GeneOntologyBiologicalProcess | distal tubule development | 1.04e-04 | 10 | 32 | 2 | GO:0072017 | |
| GeneOntologyBiologicalProcess | pronephros development | 1.04e-04 | 10 | 32 | 2 | GO:0048793 | |
| GeneOntologyBiologicalProcess | mesenchymal to epithelial transition involved in metanephros morphogenesis | 1.52e-04 | 12 | 32 | 2 | GO:0003337 | |
| GeneOntologyBiologicalProcess | regulation of nephron tubule epithelial cell differentiation | 1.80e-04 | 13 | 32 | 2 | GO:0072182 | |
| GeneOntologyBiologicalProcess | negative regulation of mesenchymal cell apoptotic process | 1.80e-04 | 13 | 32 | 2 | GO:2001054 | |
| GeneOntologyBiologicalProcess | regulation of somatic stem cell population maintenance | 1.80e-04 | 13 | 32 | 2 | GO:1904672 | |
| GeneOntologyBiologicalProcess | collecting duct development | 1.80e-04 | 13 | 32 | 2 | GO:0072044 | |
| GeneOntologyBiologicalProcess | regulation of apoptotic process involved in morphogenesis | 2.42e-04 | 15 | 32 | 2 | GO:1902337 | |
| GeneOntologyBiologicalProcess | nephron tubule epithelial cell differentiation | 2.42e-04 | 15 | 32 | 2 | GO:0072160 | |
| GeneOntologyBiologicalProcess | metanephric renal vesicle morphogenesis | 2.42e-04 | 15 | 32 | 2 | GO:0072283 | |
| GeneOntologyBiologicalProcess | regulation of apoptotic process involved in development | 3.13e-04 | 17 | 32 | 2 | GO:1904748 | |
| GeneOntologyBiologicalProcess | regulation of mesenchymal cell apoptotic process | 3.13e-04 | 17 | 32 | 2 | GO:2001053 | |
| GeneOntologyBiologicalProcess | renal vesicle morphogenesis | 3.51e-04 | 18 | 32 | 2 | GO:0072077 | |
| GeneOntologyBiologicalProcess | positive regulation of protein acetylation | 3.51e-04 | 18 | 32 | 2 | GO:1901985 | |
| GeneOntologyBiologicalProcess | mesenchymal cell apoptotic process | 3.92e-04 | 19 | 32 | 2 | GO:0097152 | |
| GeneOntologyBiologicalProcess | regulation of epithelial cell differentiation involved in kidney development | 3.92e-04 | 19 | 32 | 2 | GO:2000696 | |
| GeneOntologyBiologicalProcess | renal vesicle development | 3.92e-04 | 19 | 32 | 2 | GO:0072087 | |
| GeneOntologyBiologicalProcess | mesenchymal to epithelial transition | 4.35e-04 | 20 | 32 | 2 | GO:0060231 | |
| GeneOntologyBiologicalProcess | metanephric nephron tubule development | 4.81e-04 | 21 | 32 | 2 | GO:0072234 | |
| GeneOntologyBiologicalProcess | optic nerve development | 5.28e-04 | 22 | 32 | 2 | GO:0021554 | |
| GeneOntologyBiologicalProcess | positive regulation of branching involved in ureteric bud morphogenesis | 5.28e-04 | 22 | 32 | 2 | GO:0090190 | |
| GeneOntologyBiologicalProcess | cell differentiation involved in metanephros development | 5.28e-04 | 22 | 32 | 2 | GO:0072202 | |
| GeneOntologyBiologicalProcess | metanephric nephron epithelium development | 5.78e-04 | 23 | 32 | 2 | GO:0072243 | |
| GeneOntologyBiologicalProcess | nephron tubule formation | 5.78e-04 | 23 | 32 | 2 | GO:0072079 | |
| GeneOntologyBiologicalProcess | metanephric nephron morphogenesis | 5.78e-04 | 23 | 32 | 2 | GO:0072273 | |
| GeneOntologyBiologicalProcess | regulation of branching involved in ureteric bud morphogenesis | 6.30e-04 | 24 | 32 | 2 | GO:0090189 | |
| GeneOntologyBiologicalProcess | metanephric tubule development | 7.40e-04 | 26 | 32 | 2 | GO:0072170 | |
| GeneOntologyBiologicalProcess | negative regulation of stem cell population maintenance | 7.40e-04 | 26 | 32 | 2 | GO:1902455 | |
| GeneOntologyBiologicalProcess | peptidyl-lysine acetylation | 8.60e-04 | 28 | 32 | 2 | GO:0018394 | |
| GeneOntologyBiologicalProcess | metanephric epithelium development | 8.60e-04 | 28 | 32 | 2 | GO:0072207 | |
| GeneOntologyBiologicalProcess | regulation of protein acetylation | 8.60e-04 | 28 | 32 | 2 | GO:1901983 | |
| GeneOntologyBiologicalProcess | metanephros morphogenesis | 9.22e-04 | 29 | 32 | 2 | GO:0003338 | |
| GeneOntologyBiologicalProcess | apoptotic process involved in morphogenesis | 1.12e-03 | 32 | 32 | 2 | GO:0060561 | |
| GeneOntologyBiologicalProcess | ventricular system development | 1.58e-03 | 38 | 32 | 2 | GO:0021591 | |
| GeneOntologyBiologicalProcess | regulation of kidney development | 1.58e-03 | 38 | 32 | 2 | GO:0090183 | |
| GeneOntologyBiologicalProcess | metanephric nephron development | 1.58e-03 | 38 | 32 | 2 | GO:0072210 | |
| GeneOntologyBiologicalProcess | regulation of chromatin organization | 1.75e-03 | 40 | 32 | 2 | GO:1902275 | |
| GeneOntologyBiologicalProcess | muscle structure development | 1.82e-03 | 858 | 32 | 6 | GO:0061061 | |
| GeneOntologyBiologicalProcess | specification of animal organ identity | 1.84e-03 | 41 | 32 | 2 | GO:0010092 | |
| GeneOntologyBiologicalProcess | positive regulation of morphogenesis of an epithelium | 1.93e-03 | 42 | 32 | 2 | GO:1905332 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | 2.01e-03 | 1194 | 32 | 7 | GO:0000902 | |
| GeneOntologyBiologicalProcess | mitotic cell cycle checkpoint signaling | 2.03e-03 | 163 | 32 | 3 | GO:0007093 | |
| GeneOntologyBiologicalProcess | apoptotic process involved in development | 2.41e-03 | 47 | 32 | 2 | GO:1902742 | |
| GeneOntologyBiologicalProcess | epithelial cell differentiation involved in kidney development | 2.41e-03 | 47 | 32 | 2 | GO:0035850 | |
| GeneOntologyBiologicalProcess | dopaminergic neuron differentiation | 2.73e-03 | 50 | 32 | 2 | GO:0071542 | |
| GeneOntologyBiologicalProcess | response to epidermal growth factor | 3.17e-03 | 54 | 32 | 2 | GO:0070849 | |
| GeneOntologyCellularComponent | myofibril | 1.53e-07 | 273 | 32 | 7 | GO:0030016 | |
| GeneOntologyCellularComponent | contractile muscle fiber | 2.30e-07 | 290 | 32 | 7 | GO:0043292 | |
| GeneOntologyCellularComponent | sarcomere | 1.88e-06 | 249 | 32 | 6 | GO:0030017 | |
| GeneOntologyCellularComponent | Z disc | 3.17e-06 | 151 | 32 | 5 | GO:0030018 | |
| GeneOntologyCellularComponent | costamere | 4.92e-06 | 22 | 32 | 3 | GO:0043034 | |
| GeneOntologyCellularComponent | I band | 5.03e-06 | 166 | 32 | 5 | GO:0031674 | |
| GeneOntologyCellularComponent | anchoring junction | 8.48e-05 | 976 | 32 | 8 | GO:0070161 | |
| GeneOntologyCellularComponent | Swr1 complex | 1.75e-04 | 13 | 32 | 2 | GO:0000812 | |
| GeneOntologyCellularComponent | adherens junction | 2.96e-04 | 212 | 32 | 4 | GO:0005912 | |
| GeneOntologyCellularComponent | supramolecular fiber | 3.12e-04 | 1179 | 32 | 8 | GO:0099512 | |
| GeneOntologyCellularComponent | supramolecular polymer | 3.27e-04 | 1187 | 32 | 8 | GO:0099081 | |
| GeneOntologyCellularComponent | INO80-type complex | 8.37e-04 | 28 | 32 | 2 | GO:0097346 | |
| GeneOntologyCellularComponent | actin cytoskeleton | 1.70e-03 | 576 | 32 | 5 | GO:0015629 | |
| GeneOntologyCellularComponent | cell-cell junction | 1.90e-03 | 591 | 32 | 5 | GO:0005911 | |
| GeneOntologyCellularComponent | kinetochore | 2.63e-03 | 181 | 32 | 3 | GO:0000776 | |
| GeneOntologyCellularComponent | sarcolemma | 3.02e-03 | 190 | 32 | 3 | GO:0042383 | |
| GeneOntologyCellularComponent | condensed chromosome, centromeric region | 3.16e-03 | 193 | 32 | 3 | GO:0000779 | |
| GeneOntologyCellularComponent | focal adhesion | 4.06e-03 | 431 | 32 | 4 | GO:0005925 | |
| GeneOntologyCellularComponent | cell-substrate junction | 4.47e-03 | 443 | 32 | 4 | GO:0030055 | |
| GeneOntologyCellularComponent | histone deacetylase complex | 7.49e-03 | 85 | 32 | 2 | GO:0000118 | |
| GeneOntologyCellularComponent | inclusion body | 8.36e-03 | 90 | 32 | 2 | GO:0016234 | |
| GeneOntologyCellularComponent | chromosome, centromeric region | 8.51e-03 | 276 | 32 | 3 | GO:0000775 | |
| GeneOntologyCellularComponent | intercellular bridge | 9.09e-03 | 94 | 32 | 2 | GO:0045171 | |
| GeneOntologyCellularComponent | SWI/SNF superfamily-type complex | 9.46e-03 | 96 | 32 | 2 | GO:0070603 | |
| GeneOntologyCellularComponent | site of double-strand break | 1.04e-02 | 101 | 32 | 2 | GO:0035861 | |
| GeneOntologyCellularComponent | condensed chromosome | 1.14e-02 | 307 | 32 | 3 | GO:0000793 | |
| GeneOntologyCellularComponent | contractile actin filament bundle | 1.16e-02 | 107 | 32 | 2 | GO:0097517 | |
| GeneOntologyCellularComponent | stress fiber | 1.16e-02 | 107 | 32 | 2 | GO:0001725 | |
| MousePheno | absent uterine horn | 3.59e-06 | 2 | 27 | 2 | MP:0009215 | |
| MousePheno | optic nerve coloboma | 1.08e-05 | 3 | 27 | 2 | MP:0010717 | |
| MousePheno | absent efferent ductules of testis | 1.08e-05 | 3 | 27 | 2 | MP:0004729 | |
| MousePheno | delayed optic fissure closure | 3.58e-05 | 5 | 27 | 2 | MP:0012536 | |
| MousePheno | abnormal optic fissure closure | 1.28e-04 | 9 | 27 | 2 | MP:0012535 | |
| MousePheno | absent epididymis | 1.28e-04 | 9 | 27 | 2 | MP:0004727 | |
| MousePheno | abnormal midbrain morphology | 1.89e-04 | 151 | 27 | 4 | MP:0000897 | |
| MousePheno | abnormal efferent ductules of testis morphology | 1.95e-04 | 11 | 27 | 2 | MP:0004728 | |
| MousePheno | decreased B-1b cell number | 1.95e-04 | 11 | 27 | 2 | MP:0008170 | |
| MousePheno | abnormal inner ear development | 2.34e-04 | 12 | 27 | 2 | MP:0011238 | |
| MousePheno | abnormal ear development | 2.59e-04 | 65 | 27 | 3 | MP:0003938 | |
| MousePheno | thin retina ganglion layer | 3.71e-04 | 15 | 27 | 2 | MP:0008507 | |
| MousePheno | abnormal oviduct morphology | 4.24e-04 | 16 | 27 | 2 | MP:0003574 | |
| MousePheno | abnormal sarcomere morphology | 4.27e-04 | 77 | 27 | 3 | MP:0004090 | |
| MousePheno | abnormal uterine horn morphology | 5.39e-04 | 18 | 27 | 2 | MP:0009085 | |
| Domain | Pax2_C | 4.57e-09 | 3 | 32 | 3 | IPR022130 | |
| Domain | Pax2_C | 4.57e-09 | 3 | 32 | 3 | PF12403 | |
| Domain | PAX | 3.81e-07 | 9 | 32 | 3 | SM00351 | |
| Domain | PAX | 3.81e-07 | 9 | 32 | 3 | PF00292 | |
| Domain | Paired_dom | 3.81e-07 | 9 | 32 | 3 | IPR001523 | |
| Domain | PAIRED_2 | 3.81e-07 | 9 | 32 | 3 | PS51057 | |
| Domain | PAIRED_1 | 3.81e-07 | 9 | 32 | 3 | PS00034 | |
| Domain | IG_FLMN | 1.27e-04 | 10 | 32 | 2 | SM00557 | |
| Domain | Filamin | 1.55e-04 | 11 | 32 | 2 | PF00630 | |
| Domain | Filamin/ABP280_rpt | 1.55e-04 | 11 | 32 | 2 | IPR001298 | |
| Domain | Filamin/ABP280_repeat-like | 1.55e-04 | 11 | 32 | 2 | IPR017868 | |
| Domain | FILAMIN_REPEAT | 1.55e-04 | 11 | 32 | 2 | PS50194 | |
| Domain | Actinin_actin-bd_CS | 7.04e-04 | 23 | 32 | 2 | IPR001589 | |
| Domain | ACTININ_2 | 7.04e-04 | 23 | 32 | 2 | PS00020 | |
| Domain | ACTININ_1 | 7.04e-04 | 23 | 32 | 2 | PS00019 | |
| Domain | WHTH_DNA-bd_dom | 7.43e-04 | 242 | 32 | 4 | IPR011991 | |
| Domain | PDZ | 1.78e-03 | 141 | 32 | 3 | PF00595 | |
| Domain | PDZ | 2.04e-03 | 148 | 32 | 3 | SM00228 | |
| Domain | - | 2.12e-03 | 150 | 32 | 3 | 2.30.42.10 | |
| Domain | PDZ | 2.16e-03 | 151 | 32 | 3 | PS50106 | |
| Domain | PDZ | 2.20e-03 | 152 | 32 | 3 | IPR001478 | |
| Domain | Intermediate_filament_CS | 5.20e-03 | 63 | 32 | 2 | IPR018039 | |
| Domain | CH | 5.53e-03 | 65 | 32 | 2 | SM00033 | |
| Domain | - | 6.06e-03 | 218 | 32 | 3 | 1.10.10.10 | |
| Domain | CH | 6.39e-03 | 70 | 32 | 2 | PF00307 | |
| Domain | Filament | 6.57e-03 | 71 | 32 | 2 | SM01391 | |
| Domain | - | 6.57e-03 | 71 | 32 | 2 | 1.10.418.10 | |
| Domain | IF | 6.75e-03 | 72 | 32 | 2 | PS00226 | |
| Domain | CH | 6.93e-03 | 73 | 32 | 2 | PS50021 | |
| Domain | Filament | 6.93e-03 | 73 | 32 | 2 | PF00038 | |
| Domain | CH-domain | 7.30e-03 | 75 | 32 | 2 | IPR001715 | |
| Domain | IF | 7.49e-03 | 76 | 32 | 2 | IPR001664 | |
| Pathway | WP_ID_SIGNALING | 1.82e-06 | 16 | 22 | 3 | M39359 | |
| Pathway | WP_ID_SIGNALING_PATHWAY | 6.17e-05 | 50 | 22 | 3 | MM15817 | |
| Pathway | REACTOME_FORMATION_OF_INTERMEDIATE_MESODERM | 6.47e-05 | 8 | 22 | 2 | M48014 | |
| Pathway | WP_NPHP1_DELETION_SYNDROME | 1.27e-04 | 11 | 22 | 2 | M48099 | |
| Pathway | REACTOME_FORMATION_OF_THE_NEPHRIC_DUCT | 3.50e-04 | 18 | 22 | 2 | M48242 | |
| Pubmed | PAX immunoreactivity in poorly differentiated small round cell tumors of childhood. | 7.78e-10 | 3 | 33 | 3 | 24897005 | |
| Pubmed | Pax-5 is expressed at the midbrain-hindbrain boundary during mouse development. | 7.78e-10 | 3 | 33 | 3 | 1283313 | |
| Pubmed | Id helix-loop-helix proteins antagonize pax transcription factor activity by inhibiting DNA binding. | 3.11e-09 | 4 | 33 | 3 | 11134340 | |
| Pubmed | Two Pax-binding sites are required for early embryonic brain expression of an Engrailed-2 transgene. | 3.11e-09 | 4 | 33 | 3 | 8625814 | |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | 3.91e-09 | 256 | 33 | 7 | 33397691 | |
| Pubmed | Hes1 and Hes3 regulate maintenance of the isthmic organizer and development of the mid/hindbrain. | 3.97e-09 | 21 | 33 | 4 | 11500373 | |
| Pubmed | 6.99e-09 | 652 | 33 | 9 | 31180492 | ||
| Pubmed | Roles of Pax-genes in developing and adult brain as suggested by expression patterns. | 1.55e-08 | 6 | 33 | 3 | 8126546 | |
| Pubmed | Mapping of the human homologs of the murine paired-box-containing genes. | 1.55e-08 | 6 | 33 | 3 | 8431641 | |
| Pubmed | Pax2 contributes to inner ear patterning and optic nerve trajectory. | 2.72e-08 | 7 | 33 | 3 | 8951055 | |
| Pubmed | Distinct regulators control the expression of the mid-hindbrain organizer signal FGF8. | 4.34e-08 | 8 | 33 | 3 | 11704761 | |
| Pubmed | 6.51e-08 | 9 | 33 | 3 | 7883790 | ||
| Pubmed | 6.51e-08 | 9 | 33 | 3 | 10197584 | ||
| Pubmed | Chromosomal localization of seven PAX genes and cloning of a novel family member, PAX-9. | 6.51e-08 | 9 | 33 | 3 | 7981748 | |
| Pubmed | Pax3 Hypomorphs Reveal Hidden Pax7 Functional Genetic Compensation in Utero. | 1.28e-07 | 11 | 33 | 3 | 35645295 | |
| Pubmed | 1.70e-07 | 12 | 33 | 3 | 16530751 | ||
| Pubmed | 2.21e-07 | 13 | 33 | 3 | 17166926 | ||
| Pubmed | Pax: a murine multigene family of paired box-containing genes. | 3.51e-07 | 15 | 33 | 3 | 1685142 | |
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | 3.66e-07 | 498 | 33 | 7 | 36634849 | |
| Pubmed | 6.60e-07 | 72 | 33 | 4 | 31248990 | ||
| Pubmed | 7.40e-07 | 340 | 33 | 6 | 29478914 | ||
| Pubmed | 7.46e-07 | 19 | 33 | 3 | 8575294 | ||
| Pubmed | LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow. | 7.93e-07 | 344 | 33 | 6 | 30333137 | |
| Pubmed | 8.73e-07 | 2 | 33 | 2 | 21836481 | ||
| Pubmed | 8.73e-07 | 2 | 33 | 2 | 23328975 | ||
| Pubmed | PAX2, PAX8, and PR are correlated with ovarian seromucinous borderline tumor with endometriosis. | 8.73e-07 | 2 | 33 | 2 | 35387670 | |
| Pubmed | 8.73e-07 | 2 | 33 | 2 | 8413205 | ||
| Pubmed | PAX2 and PAX8 expression in primary and metastatic renal tumors: a comprehensive comparison. | 8.73e-07 | 2 | 33 | 2 | 23194047 | |
| Pubmed | 8.73e-07 | 2 | 33 | 2 | 37977366 | ||
| Pubmed | 8.73e-07 | 2 | 33 | 2 | 22807381 | ||
| Pubmed | 8.73e-07 | 2 | 33 | 2 | 10662641 | ||
| Pubmed | 8.73e-07 | 2 | 33 | 2 | 21989345 | ||
| Pubmed | Pax8, a murine paired box gene expressed in the developing excretory system and thyroid gland. | 8.73e-07 | 2 | 33 | 2 | 1723950 | |
| Pubmed | A subset of solitary fibrous tumors express nuclear PAX8 and PAX2: a potential diagnostic pitfall. | 8.73e-07 | 2 | 33 | 2 | 26404914 | |
| Pubmed | 8.73e-07 | 2 | 33 | 2 | 24334997 | ||
| Pubmed | 8.73e-07 | 2 | 33 | 2 | 35926290 | ||
| Pubmed | 8.73e-07 | 2 | 33 | 2 | 21934480 | ||
| Pubmed | 8.73e-07 | 2 | 33 | 2 | 25500505 | ||
| Pubmed | The limits of promiscuity: isoform-specific dimerization of filamins. | 8.73e-07 | 2 | 33 | 2 | 12525170 | |
| Pubmed | Paired box genes, PAX-2 and PAX-8, are not frequently mutated in Wilms tumor. | 8.73e-07 | 2 | 33 | 2 | 16814811 | |
| Pubmed | 8.73e-07 | 2 | 33 | 2 | 1337742 | ||
| Pubmed | PAX8 and PAX5 are differentially expressed in B-cell and T-cell lymphomas. | 8.73e-07 | 2 | 33 | 2 | 23163626 | |
| Pubmed | 8.73e-07 | 2 | 33 | 2 | 26823795 | ||
| Pubmed | PAX8 and PAX2 expression in endocervical adenocarcinoma in situ and high-grade squamous dysplasia. | 8.73e-07 | 2 | 33 | 2 | 23202787 | |
| Pubmed | A novel human actin-binding protein homologue that binds to platelet glycoprotein Ibalpha. | 8.73e-07 | 2 | 33 | 2 | 9694715 | |
| Pubmed | PAX2 and PAX8 reliably distinguishes ovarian serous tumors from mucinous tumors. | 8.73e-07 | 2 | 33 | 2 | 24992169 | |
| Pubmed | 1.03e-06 | 360 | 33 | 6 | 33111431 | ||
| Pubmed | 1.87e-06 | 399 | 33 | 6 | 35987950 | ||
| Pubmed | Characterization of a novel Lbx1 mouse loss of function strain. | 1.99e-06 | 26 | 33 | 3 | 34906895 | |
| Pubmed | 1.99e-06 | 26 | 33 | 3 | 21303848 | ||
| Pubmed | 2.23e-06 | 653 | 33 | 7 | 22586326 | ||
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 22495365 | ||
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 11252955 | ||
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 1516825 | ||
| Pubmed | Regulation of c-Ret in the developing kidney is responsive to Pax2 gene dosage. | 2.62e-06 | 3 | 33 | 2 | 17047028 | |
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 32381599 | ||
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 12393796 | ||
| Pubmed | Identification of a Z-band associated protein complex involving KY, FLNC and IGFN1. | 2.62e-06 | 3 | 33 | 2 | 20206623 | |
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 7856737 | ||
| Pubmed | Diagnostic Utility of Pax8, Pax2, and NGFR Immunohistochemical Expression in Pediatric Renal Tumors. | 2.62e-06 | 3 | 33 | 2 | 28426529 | |
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 11153914 | ||
| Pubmed | Pax2.1 is required for the development of thyroid follicles in zebrafish. | 2.62e-06 | 3 | 33 | 2 | 12117823 | |
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 21263247 | ||
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 26797858 | ||
| Pubmed | 3.69e-06 | 1014 | 33 | 8 | 32416067 | ||
| Pubmed | 3.76e-06 | 707 | 33 | 7 | 19738201 | ||
| Pubmed | 3.79e-06 | 708 | 33 | 7 | 39231216 | ||
| Pubmed | 5.23e-06 | 4 | 33 | 2 | 23196794 | ||
| Pubmed | Functional equivalence of the transcription factors Pax2 and Pax5 in mouse development. | 5.23e-06 | 4 | 33 | 2 | 10934015 | |
| Pubmed | 5.23e-06 | 4 | 33 | 2 | 11793341 | ||
| Pubmed | Pax2/Pax8-defined subdomains and the occurrence of apoptosis in the posterior placodal area of mice. | 5.23e-06 | 4 | 33 | 2 | 28160066 | |
| Pubmed | 5.23e-06 | 4 | 33 | 2 | 11739414 | ||
| Pubmed | Structural interaction and functional regulation of polycystin-2 by filamin. | 5.23e-06 | 4 | 33 | 2 | 22802962 | |
| Pubmed | 6.37e-06 | 494 | 33 | 6 | 26831064 | ||
| Pubmed | 7.31e-06 | 506 | 33 | 6 | 30890647 | ||
| Pubmed | 8.29e-06 | 295 | 33 | 5 | 26209609 | ||
| Pubmed | 8.72e-06 | 5 | 33 | 2 | 19366992 | ||
| Pubmed | 8.72e-06 | 5 | 33 | 2 | 7577673 | ||
| Pubmed | 8.72e-06 | 5 | 33 | 2 | 15385448 | ||
| Pubmed | 8.72e-06 | 5 | 33 | 2 | 12006559 | ||
| Pubmed | 8.72e-06 | 5 | 33 | 2 | 23503645 | ||
| Pubmed | 8.72e-06 | 5 | 33 | 2 | 8099544 | ||
| Pubmed | Different expression of synemin isoforms in glia and neurons during nervous system development. | 8.72e-06 | 5 | 33 | 2 | 16817202 | |
| Pubmed | 8.72e-06 | 5 | 33 | 2 | 17360453 | ||
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | 9.21e-06 | 1149 | 33 | 8 | 35446349 | |
| Pubmed | 1.03e-05 | 538 | 33 | 6 | 28524877 | ||
| Pubmed | 1.15e-05 | 46 | 33 | 3 | 33403043 | ||
| Pubmed | 1.16e-05 | 549 | 33 | 6 | 38280479 | ||
| Pubmed | 1.19e-05 | 844 | 33 | 7 | 25963833 | ||
| Pubmed | 1.31e-05 | 6 | 33 | 2 | 1485966 | ||
| Pubmed | 1.31e-05 | 6 | 33 | 2 | 22308434 | ||
| Pubmed | Defects in eye development in transgenic mice overexpressing the heparan sulfate proteoglycan agrin. | 1.31e-05 | 6 | 33 | 2 | 17196957 | |
| Pubmed | 1.31e-05 | 6 | 33 | 2 | 25279712 | ||
| Pubmed | 1.31e-05 | 6 | 33 | 2 | 12435636 | ||
| Pubmed | 1.41e-05 | 568 | 33 | 6 | 37774976 | ||
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | 1.47e-05 | 332 | 33 | 5 | 32786267 | |
| Pubmed | 1.83e-05 | 7 | 33 | 2 | 9405645 | ||
| Pubmed | Epithelial transformation of metanephric mesenchyme in the developing kidney regulated by Wnt-4. | 1.83e-05 | 7 | 33 | 2 | 7990960 | |
| Pubmed | A requirement for bone morphogenetic protein-7 during development of the mammalian kidney and eye. | 1.83e-05 | 7 | 33 | 2 | 7590254 | |
| Pubmed | 1.83e-05 | 7 | 33 | 2 | 16076904 | ||
| Interaction | PHLPP1 interactions | 7.45e-07 | 333 | 32 | 7 | int:PHLPP1 | |
| Interaction | DCPS interactions | 2.28e-06 | 394 | 32 | 7 | int:DCPS | |
| Interaction | NSD2 interactions | 4.38e-06 | 278 | 32 | 6 | int:NSD2 | |
| Interaction | CIT interactions | 8.09e-06 | 1450 | 32 | 11 | int:CIT | |
| Interaction | PRC1 interactions | 1.41e-05 | 973 | 32 | 9 | int:PRC1 | |
| Interaction | DNTTIP1 interactions | 1.51e-05 | 95 | 32 | 4 | int:DNTTIP1 | |
| Interaction | ID2 interactions | 2.24e-05 | 105 | 32 | 4 | int:ID2 | |
| Interaction | MIDEAS interactions | 2.50e-05 | 108 | 32 | 4 | int:MIDEAS | |
| Interaction | KIF20A interactions | 2.62e-05 | 1052 | 32 | 9 | int:KIF20A | |
| Interaction | KY interactions | 3.65e-05 | 6 | 32 | 2 | int:KY | |
| Interaction | USP25 interactions | 4.72e-05 | 127 | 32 | 4 | int:USP25 | |
| Interaction | ITGB2 interactions | 5.48e-05 | 132 | 32 | 4 | int:ITGB2 | |
| Interaction | TNIP1 interactions | 8.20e-05 | 1217 | 32 | 9 | int:TNIP1 | |
| Interaction | PTPN4 interactions | 8.54e-05 | 54 | 32 | 3 | int:PTPN4 | |
| Interaction | BRCA1 interactions | 1.00e-04 | 1249 | 32 | 9 | int:BRCA1 | |
| Interaction | SNCA interactions | 1.07e-04 | 716 | 32 | 7 | int:SNCA | |
| Interaction | SIRT7 interactions | 1.36e-04 | 744 | 32 | 7 | int:SIRT7 | |
| Interaction | ITGB3 interactions | 1.46e-04 | 170 | 32 | 4 | int:ITGB3 | |
| Interaction | ABCC12 interactions | 1.60e-04 | 12 | 32 | 2 | int:ABCC12 | |
| Interaction | ARID1B interactions | 1.71e-04 | 177 | 32 | 4 | int:ARID1B | |
| Interaction | PLOD2 interactions | 1.82e-04 | 180 | 32 | 4 | int:PLOD2 | |
| Interaction | NKX2-4 interactions | 1.88e-04 | 13 | 32 | 2 | int:NKX2-4 | |
| Interaction | MORC4 interactions | 2.18e-04 | 74 | 32 | 3 | int:MORC4 | |
| Interaction | FBXO43 interactions | 2.18e-04 | 74 | 32 | 3 | int:FBXO43 | |
| Interaction | YAP1 interactions | 2.42e-04 | 1095 | 32 | 8 | int:YAP1 | |
| Interaction | SSH1 interactions | 2.65e-04 | 79 | 32 | 3 | int:SSH1 | |
| Interaction | UHRF2 interactions | 2.72e-04 | 200 | 32 | 4 | int:UHRF2 | |
| Interaction | POU5F1 interactions | 2.75e-04 | 584 | 32 | 6 | int:POU5F1 | |
| Interaction | SUMO2 interactions | 2.93e-04 | 591 | 32 | 6 | int:SUMO2 | |
| Interaction | FN1 interactions | 3.05e-04 | 848 | 32 | 7 | int:FN1 | |
| Interaction | KCNA3 interactions | 3.59e-04 | 871 | 32 | 7 | int:KCNA3 | |
| Interaction | OFCC1 interactions | 3.68e-04 | 18 | 32 | 2 | int:OFCC1 | |
| Interaction | ECT2 interactions | 4.00e-04 | 887 | 32 | 7 | int:ECT2 | |
| Interaction | H3C1 interactions | 4.40e-04 | 901 | 32 | 7 | int:H3C1 | |
| Interaction | LONRF1 interactions | 6.45e-04 | 107 | 32 | 3 | int:LONRF1 | |
| Interaction | HSPB7 interactions | 6.60e-04 | 24 | 32 | 2 | int:HSPB7 | |
| Interaction | DTX3 interactions | 6.63e-04 | 108 | 32 | 3 | int:DTX3 | |
| Interaction | ACTC1 interactions | 6.88e-04 | 694 | 32 | 6 | int:ACTC1 | |
| Interaction | FOXP1 interactions | 6.91e-04 | 256 | 32 | 4 | int:FOXP1 | |
| Interaction | PAX8 interactions | 7.18e-04 | 111 | 32 | 3 | int:PAX8 | |
| Interaction | NAA40 interactions | 7.18e-04 | 978 | 32 | 7 | int:NAA40 | |
| Cytoband | 3q12.3 | 5.97e-05 | 16 | 33 | 2 | 3q12.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr3q12 | 7.00e-04 | 54 | 33 | 2 | chr3q12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr10p12 | 4.58e-03 | 140 | 33 | 2 | chr10p12 | |
| GeneFamily | Paired boxes | 1.31e-07 | 9 | 22 | 3 | 675 | |
| GeneFamily | Intermediate filaments Type IV | 2.11e-05 | 6 | 22 | 2 | 611 | |
| GeneFamily | PRD class homeoboxes and pseudogenes | 1.83e-04 | 92 | 22 | 3 | 521 | |
| GeneFamily | PDZ domain containing | 7.98e-04 | 152 | 22 | 3 | 1220 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 1.62e-02 | 161 | 22 | 2 | 593 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 2.02e-02 | 181 | 22 | 2 | 694 | |
| Coexpression | DESCARTES_FETAL_EYE_ASTROCYTES | 1.33e-05 | 39 | 31 | 3 | M40188 | |
| Coexpression | GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_4H_CD4_TCELL_UP | 7.83e-05 | 194 | 31 | 4 | M4187 | |
| Coexpression | LAKE_ADULT_KIDNEY_C12_THICK_ASCENDING_LIMB | 7.87e-05 | 381 | 31 | 5 | M39231 | |
| Coexpression | GSE369_PRE_VS_POST_IL6_INJECTION_IFNG_WT_LIVER_DN | 8.81e-05 | 200 | 31 | 4 | M5980 | |
| Coexpression | CAMP_UP.V1_UP | 8.81e-05 | 200 | 31 | 4 | M2720 | |
| Coexpression | MIKKELSEN_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3 | 1.06e-04 | 210 | 31 | 4 | M2010 | |
| Coexpression | MIKKELSEN_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3 | 1.21e-04 | 217 | 31 | 4 | MM861 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1-6_FGFR3_ETNPPL|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.16e-07 | 187 | 32 | 5 | 4d2115a05ec36dd179ca1d4a525f2d4501aea557 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Epcam____podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.81e-06 | 178 | 32 | 4 | 445fb243d738a34794d66f34b92dde1f3ea6738e | |
| ToppCell | droplet-Fat-BAT+GAT+MAT-30m-Epithelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.81e-06 | 178 | 32 | 4 | 8b7df6ab8709d9ab9dff97677cc4561aec2745bc | |
| ToppCell | droplet-Fat-BAT+GAT+MAT-30m-Epithelial|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.81e-06 | 178 | 32 | 4 | 58857bb8c13e0e1c6d9f5c1258f00fff62063d68 | |
| ToppCell | droplet-Fat-BAT+GAT+MAT-30m-Epithelial-epithelial_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.81e-06 | 178 | 32 | 4 | b0baf5667e3301898b3e45e974b8a8530af6a338 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_lymph_vessel-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.71e-06 | 183 | 32 | 4 | bc98df870de65aff6dab295c24cbc199c7f2aa15 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Astro-Astrocyte|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.49e-06 | 187 | 32 | 4 | 5c73010fe4c85fb5cc1273f5504821229ca0cc4b | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Astro-Astrocyte|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.49e-06 | 187 | 32 | 4 | dd1d91f101b837bba513f77defa6e6902b2c0570 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1-6_FGFR3_ETNPPL|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.49e-06 | 187 | 32 | 4 | 93c78fc7f126132eb84feb47be2c4e8c568b9e91 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Astro|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.49e-06 | 187 | 32 | 4 | ae90c263f80c36a410150d499e268d198944a3d9 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Astro|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.49e-06 | 187 | 32 | 4 | 5d3d68519c8e19f10c29f9d81712125be78ca15a | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Astro-Astrocyte|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.07e-05 | 193 | 32 | 4 | b03d908d4b8940927f72c76a1b0f237d13f39056 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Astro|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.07e-05 | 193 | 32 | 4 | 40edc07b6e7f19f6ee885fa5af0b63ef1b0f2468 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.10e-05 | 194 | 32 | 4 | 8985095f291c1b54e45f4edece49aa26e8c8b732 | |
| ToppCell | LAM-Endothelial-LymEndo|Endothelial / Condition, Lineage and Cell class | 1.19e-05 | 198 | 32 | 4 | ba64b1c95dfaa995045239d412e725596f6c482e | |
| ToppCell | PBMC_fresh-frozen|World / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.19e-05 | 198 | 32 | 4 | dcc223a0396b8b673e4ed8c6733ec6cd74e9a03a | |
| ToppCell | Parenchyma_COVID-19-Endothelial-TX-Lymphatic|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 1.21e-05 | 199 | 32 | 4 | 88f33b8dcd837abfa1d12c28719e073a7da6e979 | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Lymphatic|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.21e-05 | 199 | 32 | 4 | 64b19aff72e2a109cb5857cb248bd4712dd49b43 | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Lymphatic-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.21e-05 | 199 | 32 | 4 | 2b9e1e069b36b3a61cc3e384f4523687b0e03905 | |
| ToppCell | NS-moderate-d_0-4-Epithelial|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.24e-05 | 200 | 32 | 4 | 64462a18afca3c1a8548a857924b8166058bf958 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Epithelial-Hepatocyte_(Midlobular)|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-04 | 139 | 32 | 3 | e363c69b58cff8571ca75b91a3d052f9cbccac27 | |
| ToppCell | 343B-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_4|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.46e-04 | 143 | 32 | 3 | ce045ec7c311a1797ae562bec114f9e90604d063 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Immune-B_cells|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.52e-04 | 145 | 32 | 3 | 34cff6df39ff05995041f0c231c60a50ad1a0c1c | |
| ToppCell | RV-16._Neuronal|World / Chamber and Cluster_Paper | 1.65e-04 | 149 | 32 | 3 | 3a2f8c4173dcf9e3f8d3b8ffddbc597098adf7a9 | |
| ToppCell | facs-Limb_Muscle-forelimb_and_hindlimb-18m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-04 | 151 | 32 | 3 | f8ae05667a1db58a94be0f4e0b538bf80eb6b347 | |
| ToppCell | facs-Limb_Muscle-forelimb_and_hindlimb-18m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-04 | 151 | 32 | 3 | 7bc78aba6ab379d6eb00d4cf1843f532dfd4ce4e | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Immune-B_cells|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.74e-04 | 152 | 32 | 3 | 66f9190de155251a63a7a669374f342a75d22ea0 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Conventional_Leiomyosarcoma|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 1.78e-04 | 153 | 32 | 3 | ec6fe6b8c884fa76adc7a0f9db041f7b1567a2ee | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.30e-04 | 167 | 32 | 3 | b94e8ee8c3fcebedd8fcd719eadddc04c7513c50 | |
| ToppCell | LA-16._Neuronal|World / Chamber and Cluster_Paper | 2.34e-04 | 168 | 32 | 3 | 2fd1fd2a16ac1c5eb028f93cc3a2477c7747693e | |
| ToppCell | LA-16._Neuronal|LA / Chamber and Cluster_Paper | 2.34e-04 | 168 | 32 | 3 | c55bbfbde8bb954f1cb9af82007bdd1f8070fee3 | |
| ToppCell | COVID-19-kidney-PEC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.34e-04 | 168 | 32 | 3 | a086c306be430adf0632ba53e98cd8014d2de330 | |
| ToppCell | droplet-Fat-Gat-18m-Epithelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.55e-04 | 173 | 32 | 3 | a40a52d8041d45dc3bef74fe55945ae07aa018d6 | |
| ToppCell | droplet-Fat-Gat-18m-Epithelial-epithelial_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.55e-04 | 173 | 32 | 3 | f0b4dd1cf41d6ee6abb0e1968b8b39f4fabebcb5 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m-Mesenchymal|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.55e-04 | 173 | 32 | 3 | 66f37c1437705734b20601656fa4aa1d92ca30be | |
| ToppCell | droplet-Fat-Gat-18m-Epithelial|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.55e-04 | 173 | 32 | 3 | f3f67531f72d6d52e19c7f1f2db1ab4026fb70da | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m-Mesenchymal-nan|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.55e-04 | 173 | 32 | 3 | 649b08a409095592cccf31883be69c754411280d | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m-Mesenchymal-skeletal_muscle_satellite_cell|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.60e-04 | 174 | 32 | 3 | f230d23618a6487f2664efb2c677e0a4559e2bf4 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1_FGFR3_FOS|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.60e-04 | 174 | 32 | 3 | 53c2c132566a7682f3268c7f9138700f09c3b94d | |
| ToppCell | COVID-19-kidney-CD-IC-A|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.69e-04 | 176 | 32 | 3 | 45028197364c64e93e3ffe86aff773d47a477d49 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-enterocyte_of_epithelium_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.69e-04 | 176 | 32 | 3 | 7622f5a8e7320cc7b593141854107ecaf4adff7f | |
| ToppCell | LPS_only-Lymphocytic_B|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.73e-04 | 177 | 32 | 3 | 5ed65e08d773d157840317c72e0d43c261d438d4 | |
| ToppCell | LPS_only-Lymphocytic_B-B_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.73e-04 | 177 | 32 | 3 | c82332c5f656aa26513e4f7525d5d4d733019725 | |
| ToppCell | LPS_only-Lymphocytic_B-B_cells-B-cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.73e-04 | 177 | 32 | 3 | 8a955a7ab84c434f9ad4b467246b8be3cb479406 | |
| ToppCell | (06)_Krt4/13+|World / shred by cell type and Timepoint | 2.78e-04 | 178 | 32 | 3 | 46efdf03aa1317bc600138e871509b995e773cce | |
| ToppCell | COVID-19-kidney-Epi_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.78e-04 | 178 | 32 | 3 | 544379f5a6145429762258d426b876bb36c112f5 | |
| ToppCell | facs-Lung-EPCAM-3m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.78e-04 | 178 | 32 | 3 | 27497dbfcf9bb4dd0bf7caa0bd78c7e85f5c18ee | |
| ToppCell | facs-Lung-EPCAM-3m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.78e-04 | 178 | 32 | 3 | d348a9550db940d204706529759dc51e30506b5f | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.82e-04 | 179 | 32 | 3 | 4135f9e8cd8494cbc189e5210dded84659643fb8 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Fibroblasts-Smooth_muscle_cells|Fibroblasts / Location, Cell class and cell subclass | 2.82e-04 | 179 | 32 | 3 | 83506e00fe99b6450efd2f13f716926a0a4b03cd | |
| ToppCell | Neuroendocrine-neuroendo-1|World / Class top | 2.87e-04 | 180 | 32 | 3 | 50fdd182a083380899b5943cb5f55ffd77e2a7d4 | |
| ToppCell | RA-16._Neuronal|RA / Chamber and Cluster_Paper | 2.87e-04 | 180 | 32 | 3 | 5842febfdabac61ce970254fb0ef17a628f1b8c0 | |
| ToppCell | MatrixFB-Fibroblast-A|MatrixFB / shred on cell class and cell subclass (v4) | 2.87e-04 | 180 | 32 | 3 | adc64ad6033af705dd7b9163a83e20ef5c59f6eb | |
| ToppCell | facs-GAT-Fat-3m-Epithelial|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.91e-04 | 181 | 32 | 3 | 11cb84528f7ca084f0a92eda4f2e18e63a428fe9 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-F_(Lymphatics)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.91e-04 | 181 | 32 | 3 | b244ecaa442bbef51289d8ec574ef08fa9e96318 | |
| ToppCell | RA-16._Neuronal|World / Chamber and Cluster_Paper | 2.91e-04 | 181 | 32 | 3 | 7d22a43f887e0747f0cb87ba364ff27905ee6eec | |
| ToppCell | facs-GAT-Fat-3m-Epithelial-epithelial_cell|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.91e-04 | 181 | 32 | 3 | e97cbaafb93fdbee8e3cf4a06e6bcf121d941403 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.91e-04 | 181 | 32 | 3 | 6956ecd6264f7469a25e555673bce4eb97d28f7a | |
| ToppCell | facs-GAT-Fat-3m-Epithelial-nan|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.91e-04 | 181 | 32 | 3 | 5ffeca29e4d31a20c110d27af128ed024a79ad56 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-F_(Lymphatics)|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.91e-04 | 181 | 32 | 3 | dd79de8098edb385a0f85d0e9621503cdf76ec43 | |
| ToppCell | COVID-19-Epithelial_cells-ECM-high_epithelial|COVID-19 / group, cell type (main and fine annotations) | 3.01e-04 | 183 | 32 | 3 | dc1d380bf7564f290256cb7108063d1bd2da732b | |
| ToppCell | COVID-19-kidney-PCT-S1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.01e-04 | 183 | 32 | 3 | 6878d14026c3df6aa12e45dfad94b32fa9d9b0b7 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.01e-04 | 183 | 32 | 3 | 6847c1252d6bb105524f812658112517fd351eab | |
| ToppCell | wk_08-11-Mesenchymal-Myofibro_&_SMC-ACTC+_SMC|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 3.06e-04 | 184 | 32 | 3 | 39168ca2bbf1369c9fe87c67f0aaff5e3cd03151 | |
| ToppCell | Endothelial-B-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 3.11e-04 | 185 | 32 | 3 | 133c9dc64d564dae4aeeeca22f386aa3f13fa980 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1_FGFR3_MT1G|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.16e-04 | 186 | 32 | 3 | 41e03be964044dae690d566bd078dab3d8045eba | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.16e-04 | 186 | 32 | 3 | 5c4ffe4e4d5536ae9f8794277fe032c693e7dd56 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.16e-04 | 186 | 32 | 3 | f0c8de4f6ae9047b9108a47a2af8c5f42bc103b0 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.26e-04 | 188 | 32 | 3 | af740fa78542438fdff627ea1f74f4eee43316be | |
| ToppCell | 5'-Adult-Distal_Rectal-Endothelial-lymphatic_endothelial-LEC6_(ADAMTS4+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.26e-04 | 188 | 32 | 3 | 524a12f433c7b6f33fad36c0716afa06cd3235e9 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.26e-04 | 188 | 32 | 3 | ec0e241de2c8310b4417b9d4e2420d7a1662f1c0 | |
| ToppCell | Club-club-5|World / Class top | 3.26e-04 | 188 | 32 | 3 | 5911409108ececdb4f8112ec4bacc215e204001f | |
| ToppCell | ASK428-Endothelial-Lymphatic|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.26e-04 | 188 | 32 | 3 | c371bc340966cfe9205cbf4b62c6452f49f2559f | |
| ToppCell | 5'-Adult-Distal_Rectal-Endothelial-lymphatic_endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.26e-04 | 188 | 32 | 3 | d2610b81b3c7f22977b5e2137b1f61410fc4ef16 | |
| ToppCell | wk_15-18-Endothelial-Lymph_endothelial-SCG3+_lymphatic_endothelial|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.31e-04 | 189 | 32 | 3 | f0418851ad4042c4cd87c8729e4f0d43bdf8fccb | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_lymph_vessel|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.31e-04 | 189 | 32 | 3 | 55a1776a4ce049959b3f13a43744c7314bc1f00a | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.31e-04 | 189 | 32 | 3 | 904b8337e2cabac2f0bf5dad5598fc429581ed81 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-Epcam____podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.31e-04 | 189 | 32 | 3 | 319e42f6e2322208de78bc666fb2c074707eb4da | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 3.36e-04 | 190 | 32 | 3 | f1363f7806cfc4f14fbc1b0e8dac2de813a88eee | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.36e-04 | 190 | 32 | 3 | 1cf023e3c6924d6a06f353d4b62444b6f2fee8a7 | |
| ToppCell | normal_Lung-Endothelial_cells-Lymphatic_ECs|normal_Lung / Location, Cell class and cell subclass | 3.36e-04 | 190 | 32 | 3 | 2185db6007404a2b22325f91460dd17635be9bba | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Astro|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.36e-04 | 190 | 32 | 3 | 3a55cc5dc2549788bfe55f649686887b21a1fdd2 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1-6_FGFR3_ETNPPL|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.36e-04 | 190 | 32 | 3 | b56c55f608b30f7379941ac7d5f0f5200f305fca | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.36e-04 | 190 | 32 | 3 | 050d6e0546954675b6adbfecb67854b1e09739d1 | |
| ToppCell | COVID-19-lung-AT2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.36e-04 | 190 | 32 | 3 | 27a1a86620fe9b5ee930d388b32352206485e6d0 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Ascending_Thin_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.36e-04 | 190 | 32 | 3 | 59bbbd2c8d4b7ce46c54ca8022b1557e7e5eee2a | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Astro-Astrocyte|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.36e-04 | 190 | 32 | 3 | 1c3d601422efa60fad8565f9ccd9032b847e4a91 | |
| ToppCell | wk_20-22-Endothelial-Lymph_endothelial|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 3.41e-04 | 191 | 32 | 3 | 631f95fd80dd3678b5b2ef201abf7fe646049af6 | |
| ToppCell | BAL-Control-Epithelial-Epithelial|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.41e-04 | 191 | 32 | 3 | df8a1a6e78aa0cb941b94cb676bd6891d79f3687 | |
| ToppCell | Healthy_Control-Epithelial-Epithelial|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 3.41e-04 | 191 | 32 | 3 | 15b9386b26caaa7d15f704c4a18881e1ce918a21 | |
| ToppCell | BAL-Control-Epithelial|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.41e-04 | 191 | 32 | 3 | 9f19098f260d5542aa8ba7eb6f91b44d0db6e0a4 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.41e-04 | 191 | 32 | 3 | d0e9afe7b6334dd515d3e68892efdc76347a55e5 | |
| ToppCell | Control-Epithelial|Control / Disease group,lineage and cell class (2021.01.30) | 3.41e-04 | 191 | 32 | 3 | b78547dae8328244a47c83346447bdd787efbcae | |
| ToppCell | Children_(3_yrs)-Epithelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.41e-04 | 191 | 32 | 3 | e432c6e1ae82dddf84314ce73d2b7a991630d905 | |
| ToppCell | Healthy_Control-Epithelial-Epithelial-|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 3.41e-04 | 191 | 32 | 3 | 28caedb2e448e0c7f494100d714fa7cdcf150691 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-6|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.41e-04 | 191 | 32 | 3 | 6a8b0987e75456a257954288206da0032605ff2a | |
| ToppCell | Healthy_Control-Epithelial|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 3.41e-04 | 191 | 32 | 3 | fdcdadbfc9ccae175abe4de8c7428ac4f6a67fde | |
| ToppCell | BAL-Control-Epithelial-Epithelial|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.41e-04 | 191 | 32 | 3 | c50d6a1a6209ed4157f7c00fc24d4ecb43790f44 | |
| ToppCell | BAL-Control-Epithelial|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.41e-04 | 191 | 32 | 3 | 5129f778a9283bfac4ff322c21c5ca71da4b7174 | |
| ToppCell | COVID-19-lung-AT2|lung / Disease (COVID-19 only), tissue and cell type | 3.41e-04 | 191 | 32 | 3 | 276455a64c2c3503d5048615762eb2ee37f0ac70 | |
| Drug | hydroxyflutamide | 9.89e-06 | 103 | 30 | 4 | CID000091649 | |
| Drug | chloroacetonitrile | 1.67e-05 | 5 | 30 | 2 | CID000007856 | |
| Drug | HTHQ | 6.01e-05 | 9 | 30 | 2 | CID000119193 | |
| Drug | N-methyl-N'-nitrosourea | 6.01e-05 | 9 | 30 | 2 | CID000114836 | |
| Drug | 1,2-diethylbenzene | 7.50e-05 | 10 | 30 | 2 | CID000008657 | |
| Drug | amphetaminil | 7.50e-05 | 10 | 30 | 2 | CID000028615 | |
| Drug | 1,2-diacetylbenzene | 7.50e-05 | 10 | 30 | 2 | CID000035459 | |
| Drug | Chloropyramine hydrochloride [6170-42-9]; Up 200; 12.2uM; PC3; HT_HG-U133A | 1.02e-04 | 187 | 30 | 4 | 4589_UP | |
| Drug | Lansoprazole [103577-45-3]; Down 200; 10.8uM; HL60; HT_HG-U133A | 1.06e-04 | 189 | 30 | 4 | 2967_DN | |
| Drug | Ethoxyquin [91-53-2]; Up 200; 18.4uM; MCF7; HT_HG-U133A | 1.18e-04 | 194 | 30 | 4 | 3846_UP | |
| Drug | Propantheline bromide [50-34-0]; Up 200; 9uM; MCF7; HT_HG-U133A | 1.18e-04 | 194 | 30 | 4 | 4798_UP | |
| Drug | Guanabenz acetate [23256-50-0]; Up 200; 13.8uM; PC3; HT_HG-U133A | 1.18e-04 | 194 | 30 | 4 | 4642_UP | |
| Drug | Medrysone [2668-66-8]; Up 200; 11.6uM; PC3; HT_HG-U133A | 1.25e-04 | 197 | 30 | 4 | 4266_UP | |
| Drug | Propantheline bromide [50-34-0]; Up 200; 9uM; PC3; HT_HG-U133A | 1.27e-04 | 198 | 30 | 4 | 4214_UP | |
| Drug | Trimipramine maleate salt [521-78-8]; Up 200; 9.8uM; HL60; HT_HG-U133A | 1.27e-04 | 198 | 30 | 4 | 3004_UP | |
| Drug | Tadjakonine [11087-94-8]; Down 200; 7.4uM; HL60; HT_HG-U133A | 1.30e-04 | 199 | 30 | 4 | 2165_DN | |
| Drug | nordihydroguaiaretic acid; Up 200; 1uM; HL60; HT_HG-U133A | 1.30e-04 | 199 | 30 | 4 | 2683_UP | |
| Drug | Pipenzolate bromide [125-51-9]; Up 200; 9.2uM; HL60; HT_HG-U133A | 1.32e-04 | 200 | 30 | 4 | 2719_UP | |
| Drug | Delsoline [509-18-2]; Up 200; 8.6uM; MCF7; HT_HG-U133A | 1.32e-04 | 200 | 30 | 4 | 6075_UP | |
| Drug | M-Hb | 1.41e-04 | 77 | 30 | 3 | CID006122542 | |
| Disease | myofibrillar myopathy 5 (implicated_via_orthology) | 3.42e-06 | 3 | 32 | 2 | DOID:0080096 (implicated_via_orthology) | |
| Disease | distal muscular dystrophy 4 (implicated_via_orthology) | 3.42e-06 | 3 | 32 | 2 | DOID:0111190 (implicated_via_orthology) | |
| Disease | myopathy (implicated_via_orthology) | 1.94e-05 | 48 | 32 | 3 | DOID:423 (implicated_via_orthology) | |
| Disease | congenital hypothyroidism (implicated_via_orthology) | 1.03e-04 | 14 | 32 | 2 | DOID:0050328 (implicated_via_orthology) | |
| Disease | spine bone mineral density | 2.91e-04 | 119 | 32 | 3 | EFO_0007701 | |
| Disease | eating disorder | 5.54e-04 | 32 | 32 | 2 | EFO_0005203 | |
| Disease | smoking status measurement, diastolic blood pressure | 6.79e-04 | 159 | 32 | 3 | EFO_0006336, EFO_0006527 | |
| Disease | cervical cancer | 8.66e-04 | 40 | 32 | 2 | MONDO_0002974 | |
| Disease | free cholesterol to total lipids in IDL percentage | 1.00e-03 | 43 | 32 | 2 | EFO_0022278 | |
| Disease | cholesteryl esters to total lipids in large VLDL percentage | 1.69e-03 | 56 | 32 | 2 | EFO_0022250 | |
| Disease | factor XI measurement, fibrinogen measurement, tissue plasminogen activator measurement, factor VII measurement | 1.69e-03 | 56 | 32 | 2 | EFO_0004619, EFO_0004623, EFO_0004694, EFO_0004791 | |
| Disease | free cholesterol to total lipids in medium VLDL percentage | 1.75e-03 | 57 | 32 | 2 | EFO_0022284 | |
| Disease | fibrinogen measurement, factor VII measurement | 1.81e-03 | 58 | 32 | 2 | EFO_0004619, EFO_0004623 | |
| Disease | phospholipids:total lipids ratio | 1.89e-03 | 227 | 32 | 3 | EFO_0020946 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EGVTTVKPGDKVIPL | 91 | P40394 | |
| GKVKVPEVDVRGPKV | 596 | Q09666 | |
| GPKVKGDVDVSVPKV | 1206 | Q09666 | |
| LKGPKVKGDVDVSVP | 1931 | Q09666 | |
| GPKVKGDVDVSLPKV | 4396 | Q09666 | |
| PKVDVKGPKVGIDTP | 4551 | Q09666 | |
| PKVKGDFDVSVPKVE | 4861 | Q09666 | |
| IGGSKPKVATPKVVE | 76 | Q06710 | |
| GVIGGSKPKVATPKV | 81 | Q02548 | |
| TAEKPGKEEDVVTPK | 1846 | Q14676 | |
| SGNPEVKVKGIDPVI | 441 | P78333 | |
| ELSKVEGKTGTPEKP | 391 | Q92993 | |
| KDVVDPSKVKIAGPG | 1416 | O75369 | |
| GGPEEEAEKPVKTKT | 21 | Q8WW12 | |
| GPTGPVATEVVDKEK | 1081 | Q9C000 | |
| VTVKGPKGTEEPVKV | 511 | Q14315 | |
| PVKDVVDPGKVKCSG | 1436 | Q14315 | |
| IIPGSKEETPSKEGK | 216 | Q5T2T1 | |
| GVKVVIVNPETKGPV | 1371 | Q9P265 | |
| QKGEPKEVVKPVPIT | 96 | Q96HC4 | |
| GVIGGSKPKVATPKV | 81 | Q02962 | |
| IKPLKGKVPAGVDVI | 491 | Q9HDB9 | |
| PQPGIGDVKVIEKAT | 46 | P0CF75 | |
| KVPPSTQVKKGEETE | 126 | Q9UEE9 | |
| SKEVILPIKVVGGPT | 1671 | Q4G0P3 | |
| SGNGVKKPKIEIPVT | 121 | Q9H4Z3 | |
| GSPVKVGVETTKPSK | 46 | A0M8Q6 | |
| EPLVVKAGKPVIVKI | 556 | Q86VF2 | |
| GVVPVGTEEAPKVFK | 16 | Q8IUX1 | |
| LTGKPVSVPVKVVGV | 436 | Q14DG7 | |
| GAVGEKVVKPLDVPA | 881 | O15061 | |
| SVEKVIQVPPKKVKG | 286 | Q13228 | |
| IVKDKTVGVPIEPII | 211 | Q6UXZ0 | |
| KIVKPVKVSAPRVGG | 141 | P83731 | |
| RTKPIPKKGTVEGFE | 36 | P37108 | |
| PKKLKSVTPVGTEEE | 1856 | P12270 | |
| GPVRNVVKGEKVKPV | 161 | Q9NZR1 | |
| VVKGEKVKPVFEEPP | 166 | Q9NZR1 | |
| PPTIEEKVAKKSGGA | 2086 | P18583 | |
| VEEKGKSPVSKSPVE | 661 | P07197 |